Skip to main content

Tussionex Pennkinetic News

Related terms: Tussionex

Just 1 in 5 Americans Struggling With Opioid Misuse Gets Meds That Can Help

MONDAY, Aug. 7, 2023 – The U.S. opioid abuse epidemic wages on, and overdose deaths continue to rise, yet just 1 in 5 people receives potentially lifesaving medication such as methadone,...

FDA Medwatch Alert: Prescription Opioid Cough and Cold Medicines: Drug Safety Communication - FDA Requires Labeling Changes

ISSUE: FDA is requiring safety labeling changes for prescription cough and cold medicines containing codeine or hydrocodone to limit the use of these products to adults 18 years and older because the...

FDA Medwatch Alert: Long-Acting Hydrocodone-Containing Cough Product (marketed as Tussionex Pennkinetic Extended-Release Suspension)

[Posted 03/11/2008] FDA informed healthcare professionals of life-threatening adverse events and death in patients, including children, who have received Tussionex Pennkinetic Extended-Release...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Cough, Cold Symptoms

Tussionex Pennkinetic patient information at Drugs.com